Update on the efficacy and safety of sodium-glucose cotransporter 2 inhibitors in Asians and non-Asians
Fujita, Inagaki (2019) Update on the efficacy and safety of sodium-glucose cotransporter 2 inhibitors in Asians and non-Asians J Diabetes Investig (IF: 3.2) 10(6) 1408-1410Abstract
Benefits and risks of SGLT2 inhibitor use.[Image: see text]
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825932http://www.ncbi.nlm.nih.gov/pubmed/31541588
http://dx.doi.org/10.1111/jdi.13150